Migraine Pathophysiology, Headache: The Journal of Head and Face Pain, vol.24, issue.s1, pp.14-24, 2005. ,
DOI : 10.1093/brain/awf118
Experimental migraine models and their relevance in migraine therapy, Cephalalgia, vol.8, issue.6, pp.642-659, 2006. ,
DOI : 10.1007/s00210-004-0968-8
Association Between Polymorphism in the Chemokine Receptor CX3CR1 and Coronary Vascular Endothelial Dysfunction and Atherosclerosis, Circulation Research, vol.89, issue.5, pp.401-407, 2001. ,
DOI : 10.1161/hh1701.095642
The Chemokine Fractalkine Inhibits Fas-Mediated Cell Death of Brain Microglia, The Journal of Immunology, vol.165, issue.1, pp.397-403, 2000. ,
DOI : 10.4049/jimmunol.165.1.397
Chemokines, chemokine receptors and pain, Trends in Immunology, vol.26, issue.10, pp.529-534, 2005. ,
DOI : 10.1016/j.it.2005.08.001
Chemokine receptors: signposts to brain development and disease, Nature Reviews Neuroscience, vol.4, issue.6, pp.444-455, 2003. ,
DOI : 10.1038/nrn1116
Control of microglial neurotoxicity by the fractalkine receptor, Nature Neuroscience, vol.24, issue.7, pp.917-924, 2006. ,
DOI : 10.1038/nn1715
Fractalkine modulates TNF-? secretion and neurotoxicity induced by microglial activation, Glia, vol.65, issue.4, pp.305-315, 2000. ,
DOI : 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V
Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions, European Journal of Neuroscience, vol.5, issue.5, pp.1150-1160, 2004. ,
DOI : 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V
The CX3C Chemokine Fractalkine Induces Vascular Dysfunction by Generation of Superoxide Anions, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.27, issue.1, pp.55-62, 2007. ,
DOI : 10.1161/01.ATV.0000251535.30191.60
Rapid Progression to AIDS in HIV+ Individuals with a Structural Variant of the Chemokine Receptor CX3CR1, Science, vol.287, issue.5461, pp.2274-2277, 2000. ,
DOI : 10.1126/science.287.5461.2274
Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease, Blood, vol.97, issue.7, pp.1925-1928, 2001. ,
DOI : 10.1182/blood.V97.7.1925
Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans, Journal of Clinical Investigation, vol.111, issue.8, pp.1241-1250, 2003. ,
DOI : 10.1172/JCI16790
Association between migraine and endothelin type A receptor (ETA -231 A/G) gene polymorphism, Neurology, vol.56, issue.10, pp.1273-1277, 2001. ,
DOI : 10.1212/WNL.56.10.1273
Adverse Associations Between CX3CR1 Polymorphisms and Risk of Cardiovascular or Cerebrovascular Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.4, pp.847-853, 2005. ,
DOI : 10.1161/01.ATV.0000157150.23641.36
Variant of the Chemokine Receptor CX3CR1, Journal of Biological Chemistry, vol.279, issue.19, pp.19649-19657, 2004. ,
DOI : 10.1074/jbc.M313457200
Proline 326 in the C Terminus of Murine CX3CR1 Prevents G-Protein and Phosphatidylinositol 3-Kinase-Dependent Stimulation of Akt and Extracellular Signal-Regulated Kinase in Chinese Hamster Ovary Cells, Journal of Pharmacology and Experimental Therapeutics, vol.316, issue.1, pp.356-363, 2006. ,
DOI : 10.1124/jpet.105.093039
Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion, Blood, vol.103, issue.2, pp.407-412, 2004. ,
DOI : 10.1182/blood-2002-10-3260